[HTML][HTML] Warfarin usage in patients with atrial fibrillation undergoing hemodialysis in indonesian population

MR Akbar, M Febrianora, M Iqbal - Current Problems in Cardiology, 2023 - Elsevier
Background—The data about the efficacy and safety of warfarin usage in atrial fibrillation
(AF) in hemodialysis patients is still limited, especially in the Asia population. Methods—The …

Vitamin K Effects on Gas6 and Soluble Axl Receptors in Intensive Care Patients: An Observational Screening Study

U Schött, C Augustsson, L Lilover, CU Nilsson… - Nutrients, 2021 - mdpi.com
Growth arrest-specific gene 6 protein (Gas6) is avitamin K-dependent tissue bound protein.
Gas6 has been shown to promote growth and therapy resistance among different types of …

Matrix gla protein, a potential marker of tissue remodelling and physiological ageing of the gut in crohn's disease

S Vieujean, R Gillard, P Delanaye… - Scandinavian Journal …, 2024 - Taylor & Francis
Background The inactive dephosphorylated and uncarboxylated form of the matrix Gla
protein (dp-ucMGP) has been shown to be increased in plasma of inflammatory bowel …

Evaluation of inactive Matrix-Gla-Protein (MGP) as a biomarker for incident and recurrent kidney stones

V Castiglione, H Pottel, JC Lieske, P Lukas… - Journal of …, 2020 - Springer
Abstract Background Matrix-Gla-protein (MGP) is an inhibitor of vascular calcification. Its
dephosphorylated and uncarboxylated inactive form, dpucMGP, is a marker of vitamin K …

Functional deficiency of vitamin K in hemodialysis patients in Upper Silesia in Poland

K Wyskida, A Żak-Gołąb, J Wajda, D Klein… - … urology and nephrology, 2016 - Springer
Purpose Functional vitamin K deficiency (both K 1 and K 2) is postulated to be one of the
most relevant links between chronic kidney disease and vascular calcification in …

Impact of stopping vitamin K antagonist therapy on concentrations of dephospho-uncarboxylated Matrix Gla protein

P Delanaye, BE Dubois, P Lukas, P Peters… - Clinical Chemistry and …, 2015 - degruyter.com
Several experimental and clinical studies suggest that vitamin K antagonist (VKA) therapy is
a risk factor for the development of vascular calcifications and calciphylaxis in hemodialysis …

慢性肾脏病血管钙化的生物标志物

焦咏宜, 张晓良 - 肾脏病与透析肾移植杂志, 2022 - njcndt.com
血管钙化是慢性肾脏病(CKD) 最常见的并发症之一, 是影响CKD 患者预后的主要因素.
血管钙化的早期诊断, 及时干预和进展评估对于改善预后至关重要. 近些年 …

Methods for assessment of vitamin K

RM Górska - Laboratory assessment of vitamin status, 2019 - Elsevier
There is a great need for the development of robust, reliable methods for the quantitative
determination of vitamin K. This chapter provides an overview of the important principles and …

Comparison of safety profiles of new oral anticoagulants with warfarin using the Japanese spontaneous reporting database

K Hosohata, S Oyama, I Niinomi, T Wakabayashi… - Clinical Drug …, 2019 - Springer
Background The development of new oral anticoagulants (NOACs) has led to an alternative
to treatment with warfarin. However, real-world data on comparing safety profiles of NOACs …

Effects of Combined Vitamin K2 and Vitamin D3 Supplementation on Na[18F]F PET/MRI in Patients with Carotid Artery Disease: The INTRICATE Rationale and Trial …

A Florea, ME Kooi, W Mess, LJ Schurgers, J Bucerius… - Nutrients, 2021 - mdpi.com
INTRICATE is a prospective double-blind placebo-controlled feasibility study, assessing the
influence of combined vitamin K2 and vitamin D3 supplementation on micro-calcification in …